MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Home・Akcijų sąrašas・Pulmatrix Inc

Pulmatrix Inc

Uždarymo kaina

2.58 -0.39

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.58

Max

2.64

Pagrindiniai rodikliai
By Trading Economics
Pajamos	672K -877K
Pelnas, tenkantis vienai akcijai	-0.24
Pelno marža	-60,266.667
Darbuotojai	2
EBITDA	671K -877K

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-8.3M 9.6M
Ankstesnė atidarymo kaina	2.97
Ankstesnė uždarymo kaina	2.58

Pulmatrix Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-25 23:49; UTC

Rinkos pokalbiai

Oil Falls on Possible Technical Correction -- Market Talk

2026-01-25 23:43; UTC

Rinkos pokalbiai

Correction to Gold Rises Above $5000/oz Market Talk

2026-01-25 23:43; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-25 23:43; UTC

Rinkos pokalbiai

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

2026-01-25 23:36; UTC

Rinkos pokalbiai

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

2026-01-25 19:30; UTC

Įsigijimai, susijungimai, perėmimai

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

2026-01-25 19:30; UTC

Įsigijimai, susijungimai, perėmimai

Companies Had Been Discussing Roughly $30B Deal -- WSJ

2026-01-25 19:30; UTC

Įsigijimai, susijungimai, perėmimai

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

2026-01-24 09:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-01-24 09:20; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2026-01-24 09:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-24 09:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-24 06:18; UTC

Įsigijimai, susijungimai, perėmimai

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

2026-01-23 22:30; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-23 22:30; UTC

Rinkos pokalbiai

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

2026-01-23 22:03; UTC

Uždarbis

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

2026-01-23 21:52; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

2026-01-23 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2026-01-23 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-23 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-01-23 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-01-23 21:39; UTC

Uždarbis

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

2026-01-23 21:15; UTC

Įsigijimai, susijungimai, perėmimai

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

2026-01-23 21:12; UTC

Uždarbis

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

2026-01-23 20:31; UTC

Uždarbis

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

2026-01-23 20:12; UTC

Rinkos pokalbiai

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

2026-01-23 20:07; UTC

Rinkos pokalbiai

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

2026-01-23 19:36; UTC

Rinkos pokalbiai

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

2026-01-23 19:30; UTC

Rinkos pokalbiai

Uždarbis

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

2026-01-23 19:18; UTC

Rinkos pokalbiai

Gold and Silver Step Up to More Records -- Market Talk

Akcijų palyginimas

Kainos pokytis

Pulmatrix Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių Pulmatrix Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.